{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:20:02Z","timestamp":1787163602933,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00247-018-4246-1","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T01:57:17Z","timestamp":1537149437000},"page":"23-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-9822","authenticated-orcid":false,"given":"Claudia","family":"Martinez-Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul P.","family":"Jariwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Highmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Watanabe","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stimec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"4246_CR1","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/art.34332","volume":"64","author":"AP Demidowich","year":"2012","unstructured":"Demidowich AP, Freeman AF, Kuhns DB et al (2012) Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum 64:2022\u20132027","journal-title":"Arthritis Rheum"},{"key":"4246_CR2","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","volume":"11","author":"CA Wise","year":"2002","unstructured":"Wise CA, Gillum JD, Seidman CE et al (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961\u2013969","journal-title":"Hum Mol Genet"},{"key":"4246_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1086\/302866","volume":"66","author":"HB Yeon","year":"2000","unstructured":"Yeon HB, Lindor NM, Seidman JG et al (2000) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 66:1443\u20131448","journal-title":"Am J Hum Genet"},{"key":"4246_CR4","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1074\/jbc.M112.443077","volume":"288","author":"D Wang","year":"2013","unstructured":"Wang D, H\u00f6ing S, Patterson HC et al (2013) Inflammation in mice ectopically expressing human pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome-associated PSTPIP1 A230T mutant proteins. J Biol Chem 288:4594\u20134601","journal-title":"J Biol Chem"},{"key":"4246_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","volume":"72","author":"NM Lindor","year":"1997","unstructured":"Lindor NM, Arsenault TM, Solomon H et al (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72:611\u2013615","journal-title":"Mayo Clin Proc"},{"key":"4246_CR6","unstructured":"Online Mendelian Inheritance in Man (2018) National Center for Biotechnology Information website. http:\/\/www.ncbi.nlm.nih.gov\/omim . Accessed 1 March 2018"},{"key":"4246_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","volume":"45","author":"B Tallon","year":"2006","unstructured":"Tallon B, Corkill M (2006) Peculiarities of PAPA syndrome. Rheumatology 45:1140\u20131143","journal-title":"Rheumatology"},{"key":"4246_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/138920210793175921","volume":"11","author":"EJ Smith","year":"2010","unstructured":"Smith EJ, Allantaz F, Bennet L et al (2010) Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics 11:519\u2013527","journal-title":"Curr Genomics"},{"key":"4246_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s15010-017-0996-1","volume":"45","author":"W Loffler","year":"2017","unstructured":"Loffler W, Lohse P, Weihmayr T et al (2017) Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial counts. Infection 45:395\u2013402","journal-title":"Infection"},{"key":"4246_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/BOR.0000000000000314","volume":"28","author":"D Holzinger","year":"2016","unstructured":"Holzinger D, Roth J (2016) Alarming consequences \u2014 autoinflammatory disease spectrum due to mutations in proline-serine threonine phosphatase-interacting protein 1. Curr Opin Rheumatol 28:550\u2013559","journal-title":"Curr Opin Rheumatol"},{"key":"4246_CR11","first-page":"956","volume":"32","author":"BM Fathalla","year":"2014","unstructured":"Fathalla BM, Al-Wahadneh AM, Al-Mutawa M et al (2014) A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome. Clin Exp Rheumatol 32:956\u2013958","journal-title":"Clin Exp Rheumatol"},{"key":"4246_CR12","doi-asserted-by":"crossref","unstructured":"Wise CA, Bennet LB, Pascual V et al (2000) Localization of a gene for familial recurrent arthritis 43:2041\u20132045","DOI":"10.1002\/1529-0131(200009)43:9<2041::AID-ANR15>3.0.CO;2-G"},{"key":"4246_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpeds.2004.08.001","volume":"145","author":"E Cortis","year":"2004","unstructured":"Cortis E, Benedetti DF, Insalaco A et al (2004) Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome. J Pediatr 145:851\u2013855","journal-title":"J Pediatr"},{"key":"4246_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/rheumatology\/keh479","volume":"44","author":"MP Dierselhuis","year":"2005","unstructured":"Dierselhuis MP, Frenkel J, Wulffraat NM et al (2005) Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology 44:406\u2013408","journal-title":"Rheumatology"},{"key":"4246_CR15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","volume":"161","author":"M Brenner","year":"2009","unstructured":"Brenner M, Ruzicka G, Plewig G (2009) Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 161:1199\u20131201","journal-title":"Br J Dermatol"},{"key":"4246_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/RHU.0b013e3181e969b9","volume":"16","author":"ND Tofteland","year":"2010","unstructured":"Tofteland ND, Shaver TS (2010) Clinical efficacy of etanercept for treatment of PAPA syndrome. J Clin Rheumatol 16:244\u2013245","journal-title":"J Clin Rheumatol"},{"key":"4246_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2009.126185","volume":"70","author":"MA Schellevis","year":"2011","unstructured":"Schellevis MA, Stoffels M, Hoppenreijs EPAH et al (2011) Variable expression and treatment of PAPA syndrome. Ann Rheum Dis 70:1168\u20131170","journal-title":"Ann Rheum Dis"},{"key":"4246_CR18","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3899\/jrheum.140060","volume":"41","author":"R Caorsi","year":"2014","unstructured":"Caorsi R, Picco P, Buoncompagni A et al (2014) Osteolytic lesion in PAPA syndrome responding to anti-interleukin 1 treatment. J Rheumatol 41:2333\u20132334","journal-title":"J Rheumatol"},{"key":"4246_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/rheumatology\/kew031","volume":"55","author":"A Omenetti","year":"2016","unstructured":"Omenetti A, Carta S, Caorsi R et al (2016) Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome. Rheumatology 55:1325\u20131335","journal-title":"Rheumatology"},{"key":"4246_CR20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.56.4.570","volume":"56","author":"JC Jacobs","year":"1975","unstructured":"Jacobs JC, Goetzi EJ (1975) Streaking leukocyte factor, arthritis, and pyoderma gangrenosum. Pediatrics 56:570\u2013578","journal-title":"Pediatrics"},{"key":"4246_CR21","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.2135380100","volume":"100","author":"NG Shoham","year":"2003","unstructured":"Shoham NG, Centola M, Mansfield E et al (2003) Pyrin binds PSTPIP1\/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 100:13501\u201313506","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4246_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.it.2004.07.007","volume":"25","author":"MF McDermott","year":"2004","unstructured":"McDermott MF (2004) A common pathway in periodic fever syndromes. Trends Immunol 25:457\u2013460","journal-title":"Trends Immunol"},{"key":"4246_CR23","doi-asserted-by":"publisher","first-page":"A146","DOI":"10.1186\/1546-0096-11-S1-A146","volume":"11","author":"A Omenetti","year":"2013","unstructured":"Omenetti A, Caorsi R, Carta S et al (2013) PW02-006-PAPA syndrome clinical spectrum and IL1B release. Pediatr Rheumatol 11:A146","journal-title":"Pediatr Rheumatol"},{"key":"4246_CR24","doi-asserted-by":"publisher","first-page":"08","DOI":"10.1186\/1546-0096-13-S1-O8","volume":"13","author":"R Caorsi","year":"2015","unstructured":"Caorsi R, Marotto D, Insalaco A et al (2015) The phenotypic variability of PAPA syndrome: evidence from the Eurofever registry. Pediatr Rheumatol 13:08","journal-title":"Pediatr Rheumatol"},{"key":"4246_CR25","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.4049\/jimmunol.176.10.5898","volume":"176","author":"H Yang","year":"2006","unstructured":"Yang H, Reinherz EL (2006) CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST. J Immunol 176:5898\u20135907","journal-title":"J Immunol"},{"key":"4246_CR26","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1182\/blood-2013-07-516948","volume":"123","author":"TW Starnes","year":"2014","unstructured":"Starnes TW, Bennin DA, Bing X et al (2014) The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood 123:2703\u20132714","journal-title":"Blood"},{"key":"4246_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.cdd.4401734","volume":"13","author":"JW Yu","year":"2006","unstructured":"Yu JW, Wu J, Zhang Z et al (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappa B, via ASC oligomerization. Cell Death Differ 13:236\u2013249","journal-title":"Cell Death Differ"},{"key":"4246_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1157\/13117854","volume":"130","author":"JI Arostegui","year":"2008","unstructured":"Arostegui JI, Yag\u00fce J (2008) Hereditary systemic autoinflammatory diseases. Part II: cryopyrin-associated periodic syndromes, pediatric systemic granulomatosis and PAPA syndrome. Med Clin 130:429\u2013438","journal-title":"Med Clin"},{"key":"4246_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","volume":"66","author":"M Braun-Falco","year":"2012","unstructured":"Braun-Falco M, Kovnerystyy O, Lohse P et al (2012) Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 66:409\u2013415","journal-title":"J Am Acad Dermatol"},{"key":"4246_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1590\/0037-8682-0001-2014","volume":"47","author":"JR Lambertucci","year":"2014","unstructured":"Lambertucci JR (2014) Fever of undetermined origin in a patient with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA syndrome). Rev Soc Bras Med Trop 47:122","journal-title":"Rev Soc Bras Med Trop"},{"key":"4246_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bjd.14691","volume":"175","author":"AV Marzano","year":"2016","unstructured":"Marzano AV, Borghi A, Meroni PL et al (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175:882\u2013891","journal-title":"Br J Dermatol"},{"key":"4246_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrrheum.2015.105","volume":"11","author":"G Varga","year":"2015","unstructured":"Varga G, Gattorno M, Foell D et al (2015) Redox distress and genetic defects conspire in systemic autoinflammatory diseases. Nat Rev Rheumatol 11:670\u2013680","journal-title":"Nat Rev Rheumatol"},{"key":"4246_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00105-010-2115-4","volume":"62","author":"R L\u00f6hrer","year":"2011","unstructured":"L\u00f6hrer R, Eming R, Wolfrum N et al (2011) Autoinflammatory diseases as cause of wound healing defects. Hautarzt 62:524\u2013533","journal-title":"Hautarzt"},{"key":"4246_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/BOR.0b013e32835689b9","volume":"24","author":"JW Verbsky","year":"2012","unstructured":"Verbsky JW (2012) Monogenic causes of inflammatory disease in rheumatology. Curr Opin Rheumatol 24:506\u2013514","journal-title":"Curr Opin Rheumatol"},{"key":"4246_CR35","doi-asserted-by":"publisher","first-page":"513782","DOI":"10.1155\/2013\/513782","volume":"2013","author":"F Caso","year":"2013","unstructured":"Caso F, Rigante D, Vitale A (2013) Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol 2013:513782","journal-title":"Int J Rheumatol"},{"key":"4246_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00247-011-2208-y","volume":"42","author":"PG Thacker","year":"2012","unstructured":"Thacker PG, Binkovitz LA, Thomas KB (2012) Deficiency of interleukin-1-receptor antagonist syndrome: a rare auto-inflammatory condition that mimics multiple classic radiographic findings. Pediatr Radiol 42:495\u2013498","journal-title":"Pediatr Radiol"},{"key":"4246_CR37","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I, Masters SL, Ferguson PJ et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426\u20132437","journal-title":"N Engl J Med"},{"key":"4246_CR38","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1002\/art.30565","volume":"63","author":"M Stenerson","year":"2011","unstructured":"Stenerson M, Dufendach K, Aksentijevich I (2011) The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum 63:4018\u20134022","journal-title":"Arthritis Rheum"},{"key":"4246_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.mric.2009.03.002","volume":"17","author":"HE Daldrup-Link","year":"2009","unstructured":"Daldrup-Link HE, Steinbach L (2009) MR imaging of pediatric arthritis. Magn Reson Imaging Clin N Am 17:451\u2013467","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"4246_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrrheum.2009.209","volume":"5","author":"C Macaubas","year":"2009","unstructured":"Macaubas C, Nguyen K, Milojevic D et al (2009) Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 5:616\u2013626","journal-title":"Nat Rev Rheumatol"},{"key":"4246_CR41","first-page":"379","volume":"6","author":"EJ Oberle","year":"2014","unstructured":"Oberle EJ, Harris JG, Verbsky JW (2014) Polyarticular juvenile idiopathic arthritis-epidemiology and management approaches. J Clin Epidemiol 6:379\u2013393","journal-title":"J Clin Epidemiol"},{"key":"4246_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2214\/AJR.14.12891","volume":"204","author":"J Monsalve","year":"2015","unstructured":"Monsalve J, Kan JH (2015) Septic arthritis in children: frequency of coexisting unsuspected osteomyelitis and implications on imaging work-up and management. AJR Am J Roentgenol 204:1289\u20131295","journal-title":"AJR Am J Roentgenol"},{"key":"4246_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2214\/ajr.182.1.1820119","volume":"182","author":"M Karchevsky","year":"2004","unstructured":"Karchevsky M, Schweitzer ME, Morrison WB et al (2004) MRI findings of septic arthritis and associated osteomyelitis in adults. AJR Am J Roentgenol 182:119\u2013122","journal-title":"AJR Am J Roentgenol"},{"key":"4246_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ocl.2016.12.007","volume":"48","author":"SS Funk","year":"2017","unstructured":"Funk SS, Copley LAB (2017) Acute hematogenous osteomyelitis in children. Pathogenesis, diagnosis and treatment. Orthop Clin N Am 48:199\u2013208","journal-title":"Orthop Clin N Am"},{"key":"4246_CR45","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1007\/s00247-012-2594-9","volume":"43","author":"RP Guillerman","year":"2013","unstructured":"Guillerman RP (2013) Osteomyelitis and beyond. Pediatr Radiol 43:S193\u2013S203","journal-title":"Pediatr Radiol"},{"key":"4246_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11926-012-0239-5","volume":"14","author":"PJ Ferguson","year":"2012","unstructured":"Ferguson PJ, Sandu M (2012) Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 14:130\u2013141","journal-title":"Curr Rheumatol Rep"},{"key":"4246_CR47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/jmg.2005.030759","volume":"42","author":"PJ Ferguson","year":"2005","unstructured":"Ferguson PJ, Chen S, Tayeh MK et al (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551\u2013557","journal-title":"J Med Genet"},{"key":"4246_CR48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1468-3083.2010.03937.x","volume":"25","author":"W Chen","year":"2011","unstructured":"Chen W, Obermayer-Pietsch B, Hong JB (2011) Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol 25:637\u2013646","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4246_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1525-1470.2005.22320.x","volume":"22","author":"DS Stichweh","year":"2005","unstructured":"Stichweh DS, Punaro M, Pascual V (2005) Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22:262\u2013265","journal-title":"Pediatr Dermatol"},{"key":"4246_CR50","doi-asserted-by":"publisher","unstructured":"Khatibi K, Heit JJ, Telischak NA (2015) Cerebral vascular findings in PAPA syndrome: cerebral arterial vasculopathy or vasculitis and a posterior cerebral artery dissecting aneurysm. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2015-011753","DOI":"10.1136\/bcr-2015-011753"},{"key":"4246_CR51","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ccr3.662","volume":"4","author":"I Horiuchi","year":"2016","unstructured":"Horiuchi I, Fukatsu Y, Ushijima J et al (2016) A pregnancy-associated nonfamilial case of PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, acne) syndrome. Clin Case Rep 4:989\u2013991","journal-title":"Clin Case Rep"},{"key":"4246_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaad.2008.11.017","volume":"61","author":"J Hong","year":"2009","unstructured":"Hong J, Su Y, Chiu H (2009) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene. J Am Acad Dermatol 61:533\u2013535","journal-title":"J Am Acad Dermatol"},{"key":"4246_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.semarthrit.2012.05.006","volume":"42","author":"MT Nguyen","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C et al (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254\u2013265","journal-title":"Semin Arthritis Rheum"},{"key":"4246_CR54","doi-asserted-by":"publisher","first-page":"E1105","DOI":"10.1503\/cmaj.170843","volume":"189","author":"R Basmaci","year":"2017","unstructured":"Basmaci R, Bonacorsi S (2017) Kingella kingae: from carriage to infection. Commentary on Canadian Medical Association Journal. CMAJ 189:E1105\u2013E1106","journal-title":"CMAJ"},{"key":"4246_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00124743-200210000-00009","volume":"8","author":"AF Edrees","year":"2002","unstructured":"Edrees AF, Kaplan DL, Abdou NI (2002) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-a levels. J Clin Rheumatol 8:273\u2013275","journal-title":"J Clin Rheumatol"},{"key":"4246_CR56","doi-asserted-by":"publisher","first-page":"P207","DOI":"10.1186\/1546-0096-13-S1-P207","volume":"13","author":"M Finetti","year":"2015","unstructured":"Finetti M, Caorsi R, Marotto D et al (2015) Long-term efficacy of IL-1 blockers in PAPA patients. Pediatr Rheumatol 13:P207","journal-title":"Pediatr Rheumatol"},{"key":"4246_CR57","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/art.22842","volume":"56","author":"M Gattorno","year":"2007","unstructured":"Gattorno M, Tassi S, Carta S et al (2007) Pattern of interleukin-1 beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 56:3138\u20133148","journal-title":"Arthritis Rheum"},{"key":"4246_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/2013.jamadermatol.717","volume":"149","author":"A Geusau","year":"2013","unstructured":"Geusau A, Mothes-Luksch N, Nahavandi H et al (2013) Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol 149:209\u2013215","journal-title":"JAMA Dermatol"},{"key":"4246_CR59","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N Haar Ter","year":"2013","unstructured":"Ter Haar N, Lachmann H, \u00d6zen S et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever registry and a literature review. Ann Rheum Dis 72:678\u2013685","journal-title":"Ann Rheum Dis"},{"key":"4246_CR60","doi-asserted-by":"publisher","first-page":"P138","DOI":"10.1186\/1546-0096-13-S1-P138","volume":"13","author":"D Stone","year":"2015","unstructured":"Stone D, Ombrello A, Almeida ADJ et al (2015) Use of TNF inhibitors in the treatment of PAPA syndrome. Pediatr Rheumatol 13:P138","journal-title":"Pediatr Rheumatol"},{"key":"4246_CR61","first-page":"452","volume":"30","author":"H Lee","year":"2012","unstructured":"Lee H, Park SH, Kim SK (2012) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Clin Exp Rheumatol 30:452","journal-title":"Clin Exp Rheumatol"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-018-4246-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-018-4246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-018-4246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T11:39:28Z","timestamp":1662032368000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-018-4246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["4246"],"URL":"https:\/\/doi.org\/10.1007\/s00247-018-4246-1","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. R. M. Laxer has acted as a consultant for Sobi (manufacturer of anakinra) and Novartis (manufacturer of canakinumab). These relationships are not related to the development of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}